Nicholas J. Lodge

3.1k total citations · 1 hit paper
72 papers, 2.3k citations indexed

About

Nicholas J. Lodge is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nicholas J. Lodge has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nicholas J. Lodge's work include Ion channel regulation and function (25 papers), Cardiac electrophysiology and arrhythmias (20 papers) and Receptor Mechanisms and Signaling (18 papers). Nicholas J. Lodge is often cited by papers focused on Ion channel regulation and function (25 papers), Cardiac electrophysiology and arrhythmias (20 papers) and Receptor Mechanisms and Signaling (18 papers). Nicholas J. Lodge collaborates with scholars based in United States, Germany and Canada. Nicholas J. Lodge's co-authors include Raymond B. Darbenzio, Petr Pauček, Keith Garlid, Mark A. Smith, Gary J. Grover, Albert J. DʼAlonzo, Holt Murray, Vladimir Yarov‐Yarovoy, C. van Breemen and Diane E. Normandin and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and The Journal of Urology.

In The Last Decade

Nicholas J. Lodge

72 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardioprotective Effect of Diazoxide and Its Interaction With Mitochondrial ATP-Sensitive K⁺Channels

1997 854 citations Nicholas J. Lodge, Mark A. Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas J. Lodge United States	24	1.0k	933	528	499	395	72	2.3k
U. Panten Germany	33	1.8k 1.8×	884 0.9×	340 0.6×	522 1.0×	254 0.6×	105	3.4k
Norio Taira Japan	34	2.0k 1.9×	958 1.0×	1.8k 3.4×	969 1.9×	350 0.9×	250	4.3k
Peter Proks United Kingdom	39	2.5k 2.5×	1.3k 1.4×	542 1.0×	677 1.4×	219 0.6×	96	5.0k
Zoltán Szilvássy Hungary	27	594 0.6×	734 0.8×	497 0.9×	343 0.7×	392 1.0×	155	2.2k
Angela Monopoli Italy	33	1.3k 1.3×	162 0.2×	465 0.9×	797 1.6×	72 0.2×	93	3.2k
Winifred G. Nayler Australia	27	1.1k 1.1×	528 0.6×	1.4k 2.7×	437 0.9×	160 0.4×	130	2.6k
John C. Shryock United States	41	3.0k 3.0×	460 0.5×	3.1k 5.9×	859 1.7×	139 0.4×	105	5.3k
Keisuke Satoh Japan	26	521 0.5×	380 0.4×	439 0.8×	168 0.3×	94 0.2×	116	1.6k
Robert E. Beamish Canada	27	932 0.9×	512 0.5×	1.4k 2.6×	154 0.3×	137 0.3×	71	2.6k
Daniel Lamontagne Canada	29	493 0.5×	406 0.4×	833 1.6×	255 0.5×	121 0.3×	74	2.5k

Countries citing papers authored by Nicholas J. Lodge

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Lodge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Lodge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Lodge more than expected).

Fields of papers citing papers by Nicholas J. Lodge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Lodge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Lodge. The network helps show where Nicholas J. Lodge may publish in the future.

Co-authorship network of co-authors of Nicholas J. Lodge

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Lodge. A scholar is included among the top collaborators of Nicholas J. Lodge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Lodge. Nicholas J. Lodge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yu-Wen, Matthew A. Seager, Karen Heman, et al.. (2015). Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. Neuropharmacology. 102. 121–135. 15 indexed citations

Lodge, Nicholas J., Frederick T. Chin, Douglas D. Dischino, et al.. (2014). Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors. Nuclear Medicine and Biology. 41(6). 524–535. 14 indexed citations

McDonald, Ivar M., Robert Mate, F. Christopher Zusi, et al.. (2013). Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(6). 1684–1688. 16 indexed citations

Lelas, Snježana, Yu-Wen Li, Matthew T. Taber, et al.. (2013). NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the Gerbil forced swim test. Neuropharmacology. 73. 232–240. 5 indexed citations

Dzierba, Carolyn D., Thais M. Sielecki, Argyrios G. Arvanitis, et al.. (2012). Synthesis and structure–activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(15). 4986–4989. 5 indexed citations

Gillman, Kevin W., Michael F. Parker, Andrew P. Degnan, et al.. (2012). Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 23(2). 407–411. 10 indexed citations

Lodge, Nicholas J., Snježana Lelas, Yu-Wen Li, et al.. (2012). Pharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534. Neuropharmacology. 67. 284–293. 2 indexed citations

Zuev, Dmitry, Ronald J. Mattson, Hong Huang, et al.. (2011). Potential CRF1R PET imaging agents: N-Fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines. Bioorganic & Medicinal Chemistry Letters. 21(8). 2484–2488. 16 indexed citations

Hartz, Richard A., Vijay T. Ahuja, William D. Schmitz, et al.. (2010). Synthesis and structure–activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 1890–1894. 16 indexed citations

10.

Marcin, Lawrence R., Ronald J. Mattson, Qi Gao, et al.. (2009). Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles. Bioorganic & Medicinal Chemistry Letters. 20(3). 1027–1030. 6 indexed citations

11.

Lodge, Nicholas J. & Yu-Wen Li. (2008). Ion channels as potential targets for the treatment of depression.. PubMed. 11(5). 633–41. 25 indexed citations

12.

Gentles, Robert G., Shuanghua Hu, Michael A. Poss, et al.. (2008). Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. Bioorganic & Medicinal Chemistry Letters. 18(19). 5316–5319. 38 indexed citations

13.

Tertyshnikova, Svetlana, Ronald J. Knox, Mary Jane Plym, et al.. (2005). BL-1249 [(5,6,7,8-Tetrahydro-naphthalen-1-yl)-[2-(1 H-tetrazol-5-yl)-phenyl]-amine]: A Putative Potassium Channel Opener with Bladder-Relaxant Properties. Journal of Pharmacology and Experimental Therapeutics. 313(1). 250–259. 52 indexed citations

14.

Myers, Robert A., Mary Jane Plym, Laura J. Signor, & Nicholas J. Lodge. (2004). 1‐(2‐pyrimidinyl)‐piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat. Neurourology and Urodynamics. 23(7). 709–715. 9 indexed citations

15.

Lloyd, John, George C. Rovnyak, Saleem Ahmad, et al.. (2001). Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable I_Ks Blockers. Journal of Medicinal Chemistry. 44(23). 3764–3767. 18 indexed citations

16.

Atwal, Karnail S., Gary J. Grover, Nicholas J. Lodge, et al.. (1998). Binding of ATP-Sensitive Potassium Channel (K_ATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies. Journal of Medicinal Chemistry. 41(3). 271–275. 21 indexed citations

17.

Lodge, Nicholas J. & Mark A. Smith. (1996). The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(4). 444–451. 5 indexed citations

18.

Lodge, Nicholas J., et al.. (1993). 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1399–1405. 2 indexed citations

19.

Nouailhetas, Viviane L. A., Nicholas J. Lodge, C.H.C. Twort, & Cornelis van Breemen. (1988). The intracellular calcium stores in the rabbit trachealis. European Journal of Pharmacology. 157(2-3). 165–172. 5 indexed citations

20.

Lodge, Nicholas J. & Henry Gelband. (1988). Effects of hypoxia on calcium fluxes and force development in the neonatal rat atrium. Cardiovascular Research. 22(7). 520–526. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact